122 companies

Aroa Biosurgery

Market Cap: AU$224.3m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.65

7D

-4.4%

1Y

18.2%

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

EVT

€6.19

7D

-0.3%

1Y

-0.3%

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €213.2m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

FF

€8.76

7D

-1.8%

1Y

-3.3%

Rubicon Organics

Market Cap: CA$39.6m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

ROMJ

CA$0.66

7D

13.8%

1Y

50.0%

Mirum Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

MIRM

US$72.85

7D

-1.5%

1Y

86.8%

Photocure

Market Cap: NOK 1.6b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

PHO

NOK 58.90

7D

1.7%

1Y

9.1%

Strides Pharma Science

Market Cap: ₹75.6b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

STAR

₹820.60

7D

-3.9%

1Y

-41.4%

Organogenesis Holdings

Market Cap: US$520.1m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

ORGO

US$4.26

7D

-9.7%

1Y

49.0%

Apellis Pharmaceuticals

Market Cap: US$2.8b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

APLS

US$22.65

7D

-3.6%

1Y

-21.5%

MiMedx Group

Market Cap: US$1.0b

Develops and distributes placental tissue allografts for various sectors of healthcare.

MDXG

US$6.93

7D

-3.6%

1Y

17.3%

Trajan Group Holdings

Market Cap: AU$120.5m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

TRJ

AU$0.79

7D

7.5%

1Y

-38.0%

Navamedic

Market Cap: NOK 376.2m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

NAVA

NOK 21.50

7D

-0.9%

1Y

-28.6%

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€58.15

7D

-0.9%

1Y

-18.4%

PolyPeptide Group

Market Cap: CHF 773.6m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

New

PPGN

CHF 23.70

7D

-5.2%

1Y

-19.8%

Page 4 of 4